Recurrent Breast Cancer Completed Phase 2 Trials for Docetaxel (DB01248)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004888Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast CancerTreatment
NCT00055861Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast CancerTreatment